Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program

Establishing an innovative class of polyomavirus antivirals spanning BK and JC virus indications CANTON, Mass. — Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first-in-class drug against BK polyomavirus. BK virus infections are a major... The post Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program appeared first on Montreal Gazette.


8 d.
Science
ID: 715897831664251049


Similar News expand_more


Economics
Science
Economics
Technology
Science
Technology
Science
Science
Economics
Economics
Science
Science
Science
Science
Science
Technology
Technology
Technology
Science
Science
Economics
Science
Science
Military
Economics
Economics
Technology
Politics
Science
Science
Science
Science
Science
Science
Technology
Science
Science
Science
Sport
Science
Science
Economics
Science
Space
Technology
Science
Education
Science
Technology
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down